Digestive System Tumors

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-11-02
Clinical Trial Update: Phase I/II Clinical Study of Decitabine Combined With TQB2450 Injection or Decitabine + Anlotinib Combined With TQB2450 Injection in the Treatment of PD-1 Monoclonal Antibody-resistant Digestive System Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating decitabine with TQB2450 or decitabine with anlotinib plus TQB2450 in PD-1 inhibitor–resistant digestive system tu…